Finally, clinical trials of biological therapy in patients with RA have demonstrated reduced serum cholesterol levels associated with active inflammatory disease, and increases in lipids in patients responding to TNF inhibitors, as the inflammation resolves. This evidence concerns the gene TNF and rheumatoid arthritis.